-
-
-
-
-
-
-
Gyre Therapeutics (GYRE) Misses Q2 EPS by 2c
-
-
-
-
-
-
-
Gyre Therapeutics (GYRE) Announces Publication of Protocol for Phase 3 Trial Evaluating F351
-
-
-
-
-
-
-
Gyre Therapeutics (GYRE) Announces China’s NMPA Approval of Avatrombopag Maleate Tablets
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

